ReviewBritish journal of cancer2023

Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.

René Bruno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.